A slight negative trend in the relationship between U-Cd levels and BMD in both 2019 and 2022, as evident from the slightly downward-sloping regression lines in both years. However... حسب Aroon La-up (14095691)

الموضوعات:

Procedure of the Loughborough Intermittent Shuttle Test. حسب Dominic Michael Rasp (19959412)

الموضوعات:

S1 Raw data - حسب Dominic Michael Rasp (19959412)

الموضوعات:

Development of the limb symmetry index (LSI) over the course of the LIST. حسب Dominic Michael Rasp (19959412)

الموضوعات:

Development of hamstring strength throughout the LIST. حسب Dominic Michael Rasp (19959412)

الموضوعات:

Summary of HSS and LSI during the LIST. حسب Dominic Michael Rasp (19959412)

الموضوعات:

S2 Raw data - حسب Dominic Michael Rasp (19959412)

الموضوعات:

Set-up of the optimized 90:20 Isometric Posterior Chain Test. حسب Dominic Michael Rasp (19959412)

الموضوعات:

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides حسب Zufang Ba (11036420)

"…Among them, W₃BipY₈-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W₃BipY₈ but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W₃BipY₈. …"

Assignment of interventions to community health centers (CHCs) in districts. حسب Mehran Asadi-Aliabadi (8383110)

الموضوعات:

Estimated effects of the intervention packages on the incidence of NCDs metabolic risk factors. حسب Mehran Asadi-Aliabadi (8383110)

الموضوعات:

The difference in NCDs metabolic risk factors’ prevalence between the two surveys. حسب Mehran Asadi-Aliabadi (8383110)

الموضوعات:

CONSORT flow diagram. حسب Mehran Asadi-Aliabadi (8383110)

الموضوعات:

Demographic and economic characteristics of participants (frequencies and percentages). حسب Mehran Asadi-Aliabadi (8383110)

الموضوعات:

Districts of intervention and no intervention in IRPONT study. حسب Mehran Asadi-Aliabadi (8383110)

الموضوعات:

Flowchart of the screening process. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Result of the AMSTAR-2 assessments. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Characteristics of included reviews. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Result of the PRISMA assessments. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

Result of the ROBIS assessments. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"